Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Nov 08, 2020 9:30 AM - Nov 10, 2020 5:40 PM

Nihonbashi Life Science Building 6F, 2-3-11 Nihonbashihoncho, Chuo-ku, Tokyo, 103-0023 Japan

17th DIA Japan Annual Meeting 2020

SLS01 ICH 30th Anniversary: Summary of 30 Years and Future Prospects with the Role of Japan

Session Chair(s)

Kazuhiko  Mori, PhD, MSc

Kazuhiko Mori, PhD, MSc

Senior Managing Director

Japan Pharmaceutical Manufacturers Association (JPMA), Japan

Toshiyoshi  Tominaga, PhD

Toshiyoshi Tominaga, PhD

Project Professor

Keio University Hospital, Japan

Speaker(s)

Lenita  Lindström, LLM

Lenita Lindström, LLM

European Commission, Belgium

ICH Assembly Chair and Senior Expert, European Commission

Celia  Lourenco, PhD

Celia Lourenco, PhD

Health Canada, Canada

Director General, Biologic and Radiopharmaceutical Drugs Directorate, HPFB

Nobumasa  Nakashima

Nobumasa Nakashima

Cabinet Office, Japan

Health Policy Director, National Healthcare Policy Secretariat

Hironobu  Hiyoshi, PhD

Hironobu Hiyoshi, PhD

Japan Pharmaceutical Manufacturers Association (JPMA), Japan

Member of the ICH Management Committee and of the Assembly

Theresa  Mullin, PhD

Theresa Mullin, PhD

FDA, United States

Associate Center Director - Strategic Initiatives, CDER

Naoyuki  Yasuda, MSc

Naoyuki Yasuda, MSc

Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Associate Executive Director , Office of International Programs

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.